Gencor Industries, Inc. (GENC)

AMEXIndustrialsIndustrial - MachinerySnapshot 2026-10-23

$17.38-0.40%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Gencor Industries, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	30.65M
EPS	—	0.18
Annual ending 2027-09-30
Revenue	—	147.66M
EPS	—	0.98
Annual ending 2028-09-30
Revenue	—	153.01M
EPS	—	1.29

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Cash from operations improves to at least $6.9M by Q2 2026	Cash from operations improved from -$23.9M to $6.9M.	Under Pressure	Cash flow falls below zero in any quarter	Cash from operations: $9.505M FY2026-Q3; GAAP. Published target: >= $6.9 million. Target period is not explicitly aligned with this observation. Source published Aug 10, 20269,505,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q3. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. Cash from operating activities was positive in 2026-Q1 ($11.1 million) and 2026-Q2 ($6.9 million) but turned negative in 2026-Q3 (-$16.7 million). The cash flow trajectory is mixed with recent deterioration, indicating limited progress on consistent cash flow enhancement. Delivery assessment Sep 15, 2026
Operating income improves to at least $4.2M by Q2 2026	Operating income rose from a loss to $4.2M.	Intact	Operating income falls below zero in any quarter	Operating income: $5.802M FY2026-Q3; GAAP. Published target: >= $4.2 million. Target period is not explicitly aligned with this observation. Source published Aug 10, 20265,802,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 46e61ae9-1d8a-4bdd-a022-3c9cb68c3683. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. Operating income improved from a loss of $0.2 million in 2025-Q4 to $5.8 million in 2026-Q3, despite a dip in 2026-Q2 due to higher trade show expenses. Gross margins improved, reflecting effective cost management. The trajectory shows delivering progress on operating income improvement. Delivery assessment Sep 15, 2026
Revenue grows to at least $33.8M by Q2 2026	A primary condition in Gencor Industries, Inc.'s published investment case. The stated target is >= $33.8 million.	Under Pressure	Revenue falls below $18.8 million in any quarter	Revenue: $33.805M FY2026-Q3; GAAP. Published target: >= $33.8 million. Target period is not explicitly aligned with this observation. Source published Aug 10, 202633,805,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 46e61ae9-1d8a-4bdd-a022-3c9cb68c3683. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. Revenue increased from $18.8 million in 2025-Q4 to $33.8 million in 2026-Q3, though 2026-Q2 revenue declined year-over-year due to timing of orders. The backlog growth supports future revenue, but recent quarterly revenue shows a mixed trajectory with limited progress on consistent growth. Delivery assessment Sep 15, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-09-30 · fmp

FY2028 EPS: comparable history unavailable.

FY2028 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-10-01	Unavailable	Unavailable	1 / 1
2026-10-02	Unavailable	Unavailable	1 / 1
2026-10-03	Unavailable	Unavailable	1 / 1
2026-10-04	Unavailable	Unavailable	1 / 1
2026-10-05	Unavailable	Unavailable	1 / 1
2026-10-06	Unavailable	Unavailable	1 / 1
2026-10-07	Unavailable	Unavailable	1 / 1
2026-10-08	Unavailable	Unavailable	1 / 1
2026-10-09	Unavailable	Unavailable	1 / 1
2026-10-10	Unavailable	Unavailable	1 / 1
2026-10-11	Unavailable	Unavailable	1 / 1
2026-10-12	Unavailable	Unavailable	1 / 1
2026-10-13	Unavailable	Unavailable	1 / 1
2026-10-14	Unavailable	Unavailable	1 / 1
2026-10-15	Unavailable	Unavailable	1 / 1
2026-10-16	Unavailable	Unavailable	1 / 1
2026-10-17	Unavailable	Unavailable	1 / 1
2026-10-18	Unavailable	Unavailable	1 / 1
2026-10-19	Unavailable	Unavailable	1 / 1
2026-10-20	Unavailable	Unavailable	1 / 1
2026-10-21	Unavailable	Unavailable	1 / 1
2026-10-22	Unavailable	Unavailable	1 / 1
2026-10-23	Unavailable	Unavailable	1 / 1
2026-10-24	Unavailable	Unavailable	1 / 1

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	1	0
2026-06-01	1	0
2026-07-01	1	0
2026-08-01	1	0
2026-09-01	1	1
2026-10-01	0	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 0 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Cash from operations improves to at least $6.9M by Q2 2026Published status: Under Pressure
Operating income improves to at least $4.2M by Q2 2026Operating income: $5.802M
Revenue grows to at least $33.8M by Q2 2026Published status: Under Pressure

Next proof point

Dec 8, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.0%Typical daily move · historical

Downside history

-15.9%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Gencor Industries, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

GENC is a smaller industrial business with a multi-year view that depends on turning its backlog into consistent revenue and operating income. The thesis is intact, but execution is mixed and near-term earnings risk remains worth watching.

What's priced into Gencor Industries, Inc.

The valuation is described as cheap versus peers, though its valuation measure rose recently. The expectations gap is negative, suggesting expectations remain demanding relative to the model; the evidence also says pricing is justified and fragility is low.

What the fundamentals likely do

Near term, revenue may remain uneven: the record backlog supports management’s fiscal 2027 goal, but recent revenue was down year over year and consistent growth has lagged. Operating income and gross margins have shown progress, while erratic earnings and recent peer misses make the next report a risk to monitor.

What Gencor Industries, Inc. hinges on

The multi-year thesis depends on management converting the backlog into sustained revenue and operating income. A guidance cut on the next call would weaken the setup, while continued strength from industrial bellwethers could support sector momentum; weaker results from those peers could remove that support.

Bottom line

GENC’s strong recent performance and backlog keep the long-term thesis intact, but uneven growth, execution risk, and a headwind from the sector leave important questions for the next 1 to 3 years. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.